High‐dose tamoxifen and sulindac as first‐line treatment for desmoid tumors

• Published in: Cancer Vol. 101; no. 3; p. 652
• Main Authors: Sturt, N. Julian H., Phillips, Robin K. S., Clark, Susan K.
• Format: Journal Article
• Language: English
• Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.08.2004
• Subjects: Abdominal Neoplasms - drug therapy; Abdominal Neoplasms - mortality; Abdominal Neoplasms - pathology; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Female; Fibromatosis, Aggressive - drug therapy; Fibromatosis, Aggressive - mortality; Fibromatosis, Aggressive - pathology; Humans; Male; Maximum Tolerated Dose; Prognosis; Risk Assessment; Sulindac - administration & dosage; Survival Analysis; Tamoxifen - administration & dosage; Treatment Outcome